Jones Financial Companies’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.1M Sell
175,144
-36,315
-17% -$13.5M 0.03% 325
2026
Q1
$60.7M Buy
211,459
+140,622
+199% +$46.2M 0.03% 299
2025
Q4
$24.8M Buy
70,837
+3,068
+5% +$1.04M 0.02% 287
2025
Q3
$21.6M Buy
67,769
+18,939
+39% +$5.89M 0.01% 279
2025
Q2
$18.7M Buy
48,830
+16,894
+53% +$6.8M 0.01% 272
2025
Q1
$13.8M Buy
31,936
+17,908
+128% +$7.19M 0.01% 267
2024
Q4
$5.17M Buy
14,028
+7,653
+120% +$3.2M ﹤0.01% 359
2024
Q3
$3.34M Buy
6,375
+3,673
+136% +$1.96M ﹤0.01% 352
2024
Q2
$1.46M Buy
2,702
+2,328
+622% +$1.23M ﹤0.01% 369
2024
Q1
$194K Buy
374
+154
+70% +$76.6K ﹤0.01% 464
2023
Q4
$104K Buy
220
+2
+0.9% +$925 ﹤0.01% 400
2023
Q3
$94.9K Buy
218
+2
+0.9% +$907 ﹤0.01% 316
2023
Q2
$96K Hold
216
﹤0.01% 312
2023
Q1
$99.3K Sell
216
-75
-26% -$35.7K ﹤0.01% 308
2022
Q4
$149K Buy
291
+141
+94% +$71.6K ﹤0.01% 279
2022
Q3
$68K Sell
150
-20
-12% -$9.57K ﹤0.01% 312
2022
Q2
$82K Buy
170
+81
+91% +$40.1K ﹤0.01% 306
2022
Q1
$44K Sell
89
-54
-38% -$24.7K ﹤0.01% 360
2021
Q4
$66K Buy
143
+28
+24% +$11.8K ﹤0.01% 336
2021
Q3
$43K Sell
115
-8
-7% -$3.04K ﹤0.01% 338
2021
Q2
$47K Sell
123
-70
-36% -$26.8K ﹤0.01% 315
2021
Q1
$69K Buy
193
+149
+339% +$47.9K ﹤0.01% 312
2020
Q4
$14K Buy
+44
New +$13.5K ﹤0.01% 396
2013
Q4
Sell
-203
Closed -$17K 326
2013
Q3
$17K Buy
+203
New +$17.4K ﹤0.01% 440

Other funds holding ELV

Jones Financial Companies's ELV Position: Q2 2026 in Review

Jones Financial Companies reduced its Elevance Health (ELV) stake by 17% in Q2 2026, selling an estimated $13.5M and leaving 175,144 shares worth $69.1M. The position accounts for 0.03% of the portfolio, ranked #325.

Jones Financial Companies first reported a position in ELV in Q3 2013 and has held it in 24 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Jones Financial Companies held 175,144 shares of Elevance Health worth $69.1M as of Q2 2026.
  • Jones Financial Companies sold 36,315 Elevance Health shares in Q2 2026, an estimated $13.5M.
  • Elevance Health made up 0.03% of Jones Financial Companies's portfolio in Q2 2026, its #325 holding.
  • Jones Financial Companies first reported a position in Elevance Health in Q3 2013 and has held it in 24 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.